How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-mesothelioma-of-pleura.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Malignant mesothelioma of pleura — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant mesothelioma of pleura (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant mesothelioma of pleura, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Alimta	pemetrexed	Actavis	Folate Analog Metabolic Inhibitor	Folate receptor alpha		2004-01-01
Pemetrexe	Pemetrexe	Rongjie Tao		Serine hydroxymethyltransferase, cytosolic, Folate receptor beta, Folate transporter 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Actavis · 1 drug in Malignant mesothelioma of pleura
Rongjie Tao · 1 drug in Malignant mesothelioma of pleura

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant mesothelioma of pleura:

Cite this brief

Drug Landscape (2026). Malignant mesothelioma of pleura — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-mesothelioma-of-pleura. Accessed 2026-06-11.

Malignant mesothelioma of pleura full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing